Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Dysfunction of the corticostriatal pathway in autism spectrum disorders.

Li W, Pozzo-Miller L.

J Neurosci Res. 2019 Nov 22. doi: 10.1002/jnr.24560. [Epub ahead of print] Review.

PMID:
31758607
2.

Differences in GluN2B-Containing NMDA Receptors Result in Distinct Long-Term Plasticity at Ipsilateral versus Contralateral Cortico-Striatal Synapses.

Li W, Pozzo-Miller L.

eNeuro. 2019 Nov 27;6(6). pii: ENEURO.0118-19.2019. doi: 10.1523/ENEURO.0118-19.2019. Print 2019 Nov/Dec.

3.

The role of MeCP2 in learning and memory.

Robinson HA, Pozzo-Miller L.

Learn Mem. 2019 Aug 15;26(9):343-350. doi: 10.1101/lm.048876.118. Print 2019 Sep.

PMID:
31416907
4.

Ventral hippocampal projections to the medial prefrontal cortex regulate social memory.

Phillips ML, Robinson HA, Pozzo-Miller L.

Elife. 2019 May 21;8. pii: e44182. doi: 10.7554/eLife.44182.

5.

Loss of Mecp2 Causes Atypical Synaptic and Molecular Plasticity of Parvalbumin-Expressing Interneurons Reflecting Rett Syndrome-Like Sensorimotor Defects.

Morello N, Schina R, Pilotto F, Phillips M, Melani R, Plicato O, Pizzorusso T, Pozzo-Miller L, Giustetto M.

eNeuro. 2018 Sep 24;5(5). pii: ENEURO.0086-18.2018. doi: 10.1523/ENEURO.0086-18.2018. eCollection 2018 Sep-Oct.

6.

Cdk5 Is Essential for Amphetamine to Increase Dendritic Spine Density in Hippocampal Pyramidal Neurons.

Ferreras S, Fernández G, Danelon V, Pisano MV, Masseroni L, Chapleau CA, Krapacher FA, Mlewski EC, Mascó DH, Arias C, Pozzo-Miller L, Paglini MG.

Front Cell Neurosci. 2017 Nov 24;11:372. doi: 10.3389/fncel.2017.00372. eCollection 2017.

7.

The BDNF val-66-met Polymorphism Affects Neuronal Morphology and Synaptic Transmission in Cultured Hippocampal Neurons from Rett Syndrome Mice.

Xu X, Garcia J, Ewalt R, Nason S, Pozzo-Miller L.

Front Cell Neurosci. 2017 Jul 13;11:203. doi: 10.3389/fncel.2017.00203. eCollection 2017.

8.

A small-molecule TrkB ligand restores hippocampal synaptic plasticity and object location memory in Rett syndrome mice.

Li W, Bellot-Saez A, Phillips ML, Yang T, Longo FM, Pozzo-Miller L.

Dis Model Mech. 2017 Jul 1;10(7):837-845. doi: 10.1242/dmm.029959.

9.

EEA1 restores homeostatic synaptic plasticity in hippocampal neurons from Rett syndrome mice.

Xu X, Pozzo-Miller L.

J Physiol. 2017 Aug 15;595(16):5699-5712. doi: 10.1113/JP274450. Epub 2017 Jul 12.

10.

The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin.

Arnold M, Cross R, Singleton KS, Zlatic S, Chapleau C, Mullin AP, Rolle I, Moore CC, Theibert A, Pozzo-Miller L, Faundez V, Larimore J.

Front Cell Neurosci. 2016 Sep 22;10:218. eCollection 2016.

11.

Perineuronal Nets Suppress Plasticity of Excitatory Synapses on CA2 Pyramidal Neurons.

Carstens KE, Phillips ML, Pozzo-Miller L, Weinberg RJ, Dudek SM.

J Neurosci. 2016 Jun 8;36(23):6312-20. doi: 10.1523/JNEUROSCI.0245-16.2016.

12.

Excitatory synapses are stronger in the hippocampus of Rett syndrome mice due to altered synaptic trafficking of AMPA-type glutamate receptors.

Li W, Xu X, Pozzo-Miller L.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1575-84. doi: 10.1073/pnas.1517244113. Epub 2016 Feb 29.

13.

Rett Syndrome: Reaching for Clinical Trials.

Pozzo-Miller L, Pati S, Percy AK.

Neurotherapeutics. 2015 Jul;12(3):631-40. doi: 10.1007/s13311-015-0353-y. Review.

14.

Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.

Wang H, Pati S, Pozzo-Miller L, Doering LC.

Front Cell Neurosci. 2015 Feb 26;9:55. doi: 10.3389/fncel.2015.00055. eCollection 2015. Review.

15.

Dendritic spine dysgenesis in autism related disorders.

Phillips M, Pozzo-Miller L.

Neurosci Lett. 2015 Aug 5;601:30-40. doi: 10.1016/j.neulet.2015.01.011. Epub 2015 Jan 8. Review.

16.

Dendritic spine dysgenesis in Rett syndrome.

Xu X, Miller EC, Pozzo-Miller L.

Front Neuroanat. 2014 Sep 10;8:97. doi: 10.3389/fnana.2014.00097. eCollection 2014. Review.

17.

Excitation/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice.

Calfa G, Li W, Rutherford JM, Pozzo-Miller L.

Hippocampus. 2015 Feb;25(2):159-68. doi: 10.1002/hipo.22360. Epub 2014 Sep 25.

18.

A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome.

Xu X, Kozikowski AP, Pozzo-Miller L.

Front Cell Neurosci. 2014 Mar 7;8:68. doi: 10.3389/fncel.2014.00068. eCollection 2014.

19.

Recent Progress in Rett Syndrome and MeCP2 Dysfunction: Assessment of Potential Treatment Options.

Chapleau CA, Lane J, Larimore J, Li W, Pozzo-Miller L, Percy AK.

Future Neurol. 2013 Jan 1;8(1). doi: 10.2217/fnl.12.79.

20.
21.

MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons.

Larimore J, Ryder PV, Kim KY, Ambrose LA, Chapleau C, Calfa G, Gross C, Bassell GJ, Pozzo-Miller L, Smith Y, Talbot K, Park IH, Faundez V.

PLoS One. 2013 Jun 4;8(6):e65069. doi: 10.1371/journal.pone.0065069. Print 2013.

22.

A novel DNA-binding feature of MeCP2 contributes to Rett syndrome.

Xu X, Pozzo-Miller L.

Front Cell Neurosci. 2013 May 9;7:64. doi: 10.3389/fncel.2013.00064. eCollection 2013. No abstract available.

23.

BDNF deregulation in Rett syndrome.

Li W, Pozzo-Miller L.

Neuropharmacology. 2014 Jan;76 Pt C:737-46. doi: 10.1016/j.neuropharm.2013.03.024. Epub 2013 Apr 15. Review.

24.

Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function.

Pitcher MR, Ward CS, Arvide EM, Chapleau CA, Pozzo-Miller L, Hoeflich A, Sivaramakrishnan M, Saenger S, Metzger F, Neul JL.

Hum Mol Genet. 2013 Jul 1;22(13):2626-33. doi: 10.1093/hmg/ddt111. Epub 2013 Mar 5.

25.

The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate.

Arnold JJ, Hansen MS, Gorman GS, Inoue T, Rao V, Spellen S, Hunsinger RN, Chapleau CA, Pozzo-Miller L, Stamer WD, Challa P.

Invest Ophthalmol Vis Sci. 2013 Feb 7;54(2):1118-26. doi: 10.1167/iovs.12-10583.

PMID:
23307957
26.

Preclinical research in Rett syndrome: setting the foundation for translational success.

Katz DM, Berger-Sweeney JE, Eubanks JH, Justice MJ, Neul JL, Pozzo-Miller L, Blue ME, Christian D, Crawley JN, Giustetto M, Guy J, Howell CJ, Kron M, Nelson SB, Samaco RC, Schaevitz LR, St Hillaire-Clarke C, Young JL, Zoghbi HY, Mamounas LA.

Dis Model Mech. 2012 Nov;5(6):733-45. doi: 10.1242/dmm.011007. Review.

27.

Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice.

Li W, Calfa G, Larimore J, Pozzo-Miller L.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17087-92. doi: 10.1073/pnas.1205271109. Epub 2012 Oct 1.

28.

Hippocampal CA1 pyramidal neurons of Mecp2 mutant mice show a dendritic spine phenotype only in the presymptomatic stage.

Chapleau CA, Boggio EM, Calfa G, Percy AK, Giustetto M, Pozzo-Miller L.

Neural Plast. 2012;2012:976164. doi: 10.1155/2012/976164. Epub 2012 Jul 30.

29.

Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca(2+) -permeable TRPC6 channels.

Leuner K, Li W, Amaral MD, Rudolph S, Calfa G, Schuwald AM, Harteneck C, Inoue T, Pozzo-Miller L.

Hippocampus. 2013 Jan;23(1):40-52. doi: 10.1002/hipo.22052. Epub 2012 Jul 20.

30.

Intracellular Ca2+ stores and Ca2+ influx are both required for BDNF to rapidly increase quantal vesicular transmitter release.

Amaral MD, Pozzo-Miller L.

Neural Plast. 2012;2012:203536. doi: 10.1155/2012/203536. Epub 2012 Jul 3.

31.

Multiple approaches to investigate the transport and activity-dependent release of BDNF and their application in neurogenetic disorders.

Hartmann D, Drummond J, Handberg E, Ewell S, Pozzo-Miller L.

Neural Plast. 2012;2012:203734. doi: 10.1155/2012/203734. Epub 2012 Jun 6. Review.

32.

Divergent roles of p75NTR and Trk receptors in BDNF's effects on dendritic spine density and morphology.

Chapleau CA, Pozzo-Miller L.

Neural Plast. 2012;2012:578057. doi: 10.1155/2012/578057. Epub 2012 Mar 27.

34.

HDAC activity is required for BDNF to increase quantal neurotransmitter release and dendritic spine density in CA1 pyramidal neurons.

Calfa G, Chapleau CA, Campbell S, Inoue T, Morse SJ, Lubin FD, Pozzo-Miller L.

Hippocampus. 2012 Jul;22(7):1493-500. doi: 10.1002/hipo.20990. Epub 2011 Dec 7.

35.

Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging.

Calfa G, Hablitz JJ, Pozzo-Miller L.

J Neurophysiol. 2011 Apr;105(4):1768-84. doi: 10.1152/jn.00800.2010. Epub 2011 Feb 9.

36.

Experimental models of Rett syndrome based on Mecp2 dysfunction.

Calfa G, Percy AK, Pozzo-Miller L.

Exp Biol Med (Maywood). 2011 Jan;236(1):3-19. doi: 10.1258/ebm.2010.010261. Review.

37.

Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels.

Khoo NK, White CR, Pozzo-Miller L, Zhou F, Constance C, Inoue T, Patel RP, Parks DA.

Free Radic Biol Med. 2010 Aug 1;49(3):339-47. doi: 10.1016/j.freeradbiomed.2010.04.022. Epub 2010 Apr 25.

38.

Activity-dependent release of endogenous BDNF from mossy fibers evokes a TRPC3 current and Ca2+ elevations in CA3 pyramidal neurons.

Li Y, Calfa G, Inoue T, Amaral MD, Pozzo-Miller L.

J Neurophysiol. 2010 May;103(5):2846-56. doi: 10.1152/jn.01140.2009. Epub 2010 Mar 10.

39.

The dynamics of excitatory synapse formation on dendritic spines.

Amaral MD, Pozzo-Miller L.

Cellscience. 2009 Apr 27;5(4):19-25.

40.
41.

Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.

Chapleau CA, Calfa GD, Lane MC, Albertson AJ, Larimore JL, Kudo S, Armstrong DL, Percy AK, Pozzo-Miller L.

Neurobiol Dis. 2009 Aug;35(2):219-33. doi: 10.1016/j.nbd.2009.05.001. Epub 2009 May 12.

42.

GABA vesicles at synapses: are there 2 distinct pools?

Hablitz JJ, Mathew SS, Pozzo-Miller L.

Neuroscientist. 2009 Jun;15(3):218-24. doi: 10.1177/1073858408326431. Review.

43.

Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations.

Larimore JL, Chapleau CA, Kudo S, Theibert A, Percy AK, Pozzo-Miller L.

Neurobiol Dis. 2009 May;34(2):199-211. doi: 10.1016/j.nbd.2008.12.011. Epub 2009 Jan 3.

44.

GABAergic synapse maturation: evidence of the instructive role of activity-dependent BDNF release.

Pozzo-Miller L.

J Physiol. 2008 Nov 1;586(21):5041. doi: 10.1113/jphysiol.2008.163394. No abstract available.

45.

The actions of BDNF on dendritic spine density and morphology in organotypic slice cultures depend on the presence of serum in culture media.

Chapleau CA, Carlo ME, Larimore JL, Pozzo-Miller L.

J Neurosci Methods. 2008 Mar 30;169(1):182-90. doi: 10.1016/j.jneumeth.2007.12.006. Epub 2007 Dec 23.

46.

Kainate modulates presynaptic GABA release from two vesicle pools.

Mathew SS, Pozzo-Miller L, Hablitz JJ.

J Neurosci. 2008 Jan 16;28(3):725-31. doi: 10.1523/JNEUROSCI.3625-07.2008.

47.

BDNF induces calcium elevations associated with IBDNF, a nonselective cationic current mediated by TRPC channels.

Amaral MD, Pozzo-Miller L.

J Neurophysiol. 2007 Oct;98(4):2476-82. Epub 2007 Aug 15.

48.

Kinase activity is not required for alphaCaMKII-dependent presynaptic plasticity at CA3-CA1 synapses.

Hojjati MR, van Woerden GM, Tyler WJ, Giese KP, Silva AJ, Pozzo-Miller L, Elgersma Y.

Nat Neurosci. 2007 Sep;10(9):1125-7. Epub 2007 Jul 29.

49.

The neuronal Arf GAP centaurin alpha1 modulates dendritic differentiation.

Moore CD, Thacker EE, Larimore J, Gaston D, Underwood A, Kearns B, Patterson SI, Jackson T, Chapleau C, Pozzo-Miller L, Theibert A.

J Cell Sci. 2007 Aug 1;120(Pt 15):2683-93. Epub 2007 Jul 17.

Supplemental Content

Loading ...
Support Center